Exercise, Weight-Lifting Help in Preventing Lymphedema
Bonnie Gillis
Tuesday, March 15, 2011

Nele Devoogdt, MD, University Hospitals Leuven, BelgiumTwo studies presented at SABCS refined knowledge about how to prevent lymphedema in patients with breast cancer. In one study, manual lymph node drainage (MLD) failed to prevent lymphedema, whereas exercise was beneficial. A second study showed that a progressive weight-lifting program was effective in preventing lymphedema.
 
Lymphedema, the buildup of fluids that can develop in fatty tissues of the arm, breast, or chest after surgery or radiation therapy, cannot be cured once it starts, according to the American Cancer Society. As a result, the ACS emphasizes strategies aimed at preventing lymphedema from developing and recognizing early signs of swelling so that steps can be taken to control it.
 
Study Finds MLD Not Effective
 
Lead author Nele Devoogdt, MD, University Hospitals Leuven, Belgium, said clinicians recommend different modalities for preventing lymphedema, such as avoiding lymph restriction, preventing weight gain, and exercise. 
 
“In Belgium, we use MLD, as well, and no study thus far has evaluated it on its own,” she said. MLD is similar to massage therapy, but the skin is stretched to improve resorption of lymph and to increase lymph transport, creating a pathway from axilla to axilla from the affected arm to the healthy arm.
 
“Manual lymph drainage applied immediately after axillary lymph node dissection was not effective in preventing lymphedema, while exercise initiated immediately after surgery will prevent it,” said Devoogdt.
 
An earlier study showed that the combination of information and exercise therapy was more effective at preventing lymphedema than taking no measures, and a second study found that the combination of information, exercise therapy, and MLD was better than taking no measures to prevent lymphedema.
 
In the current study, researchers enrolled 160 women scheduled to undergo axillary lymph node dissection on one side. Their arms were measured prior to surgery. The women were randomized to receive a combination of guidelines or information on preventing lymphedema, exercise therapy, and MLD (n = 79) or a combination of guidelines and exercise but no MLD (n = 81).
 
Devoogdt said the guidelines were presented during exercise therapy. A total of 29 exercise sessions were given, and MLD was performed 1 to 3 times per week following exercise for an average of 34 sessions. After surgery, arm volume was measured at months 1, 3, 6, and 12. Patients who developed lymphedema had the affected arm bandaged and wore an elastic sleeve.
 
At all time points, more patients in the group receiving MLD developed lymphedema. At 3 months, 7% of patients in the MLD arm had lymphedema versus 5% in the non-MLD arm; at 6 months, rates of lymphedema were 12% versus 10%, respectively; and at 12 months, 23% of patients who underwent MLD had lymphedema compared with 18% of patients who did not. The time it took for patients to develop arm lymphedema was similar in both groups, as was the increase in arm volume, assessments of mental and physical quality of life, and functional problems, Devoogdt said.
 
 “This study is a good addition to what has been a data-free zone,” said Hiram S. Cody, III, MD, Memorial-Sloan Kettering Cancer Center, New York, New York, who moderated the session.
.
Research Supports Weight-Lifting
 
A second study presented at the symposium showed that weightlifting might help prevent lymphedema after treatment for breast cancer. Kathryn Schmitz, PhD, of the University of Pennsylvania’s Abramson Cancer Center, Philadelphia, previously reported that exercise limits lymphedema symptoms. In the new study of 154 breast cancer survivors without lymphedema, a slowly progressive weight-lifting program reduced the risk of developing lymphedema by 35% over 1 year.
 
With the weight-lifting program, only 11% of women developed lymphedema versus 17% of women in the control group who did not change their typical level of physical activity. The effects of the weight-lifting intervention were even more robust among women who had ≥5 lymph nodes surgically removed; these women had a nearly 70% reduction in lymphedema, with 7% of the weight-lifting group versus 22% of the control arm experiencing lymphedema.
 
These findings contradict the common assumption that women should avoid lifting anything heavier than 5 pounds after cancer treatment. The key to the weight-lifting program in this study is that it was slowly progressive. Participants enrolled at a fitness center for 1 year and attended twice-weekly 90-minute sessions for 13 weeks.
 
Sessions were led by certified fitness professionals, who explained how to use free weights and machines. The weights were increased slowly for each exercise if there was no change in arm symptoms. For the remaining 49 weeks, participants exercised independently. They were monitored monthly for changes in arm circumference and self-reported any new symptoms each week.
 
In summarizing what this study means, Schmitz noted that lymphedema is a common yet dreaded consequence of breast treatment. “Women worry that they will recover from cancer only to be plagued by this condition that limits their ability to function at home and work. Our study shows that they now have a weapon to reduce their risk of lymphedema and at the same time reap the many other health rewards of weight lifting that they may have missed out on due to decades of advice to avoid lifting so much as a grocery bag or their purse,” she said. Abstracts S5-3 and ES9-3.

Leslie R. Schover, PhD, clinical psychiatrist, professor, behavioral science, The University of Texas MD Anderson Cancer Center, discusses vaginal dryness and pain in patients with breast cancer treated with aromatase inhibitors.
Ellen T. Matloff, MS, CGC, director, Yale Cancer Genetic Counseling Program at the Yale School of Medicine/Yale Cancer Center, discusses options for BRCA1/2 carriers who are looking to reduce their risk of ovarian cancer.
Related Articles
The Centers for Medicare & Medicaid Services (CMS) is piloting a new Medicare Choices Care Model, designed to provide a new option for Medicare beneficiaries to concurrently receive palliative care services from hospice providers while also receiving services from curative care providers.
Breast cancer patients whose chemotherapy is initiated more than 60 days following surgery experience worse survival outcomes, and the impact of treatment delay is greatest among patients with stage III or triple-negative breast cancer and those whose HER2-positive tumors have been treated with trastuzumab
Continued monitoring of long-term effects of these drugs is warranted.
External Resources

American Journal of Managed Care
HCPLive
PainLive
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Blogs
OncNurse TV
Oncology Nurses
Publications
Specialties
Web Exclusives


About Us
Advertise
Advisory Board
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright OncLive 2006-2013
Intellisphere, LLC. All Rights Reserved.